Vincula Biotech Group is a biotechnology ecosystem covering the entire chain of regenerative medicine and cell & gene therapy. We are a unique platform of research laboratories, biobanks, manufacturing facilities, authorized clinics and hospitals. Our goal is to transform innovative treatments into effective, standardized, personalized and accessible therapies.
As the first privately-owned biotechnology group of its kind, we seamlessly integrate all the processes under centralized leadership and add the advantages of business logic and efficient project and financial management to the sector.
Under the former name of Forever Young, Vincula Biotech Group acquired Educell and Biobanka (members of MBSI) and Parks surgical hospital, transforming itself into a holding of companies.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Ulica Omladinskih Brigada 90v, Airport City Belgrade,1700 Rose Building,vii Floor,serbia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vinculabiotech.com
- Keywords
- Trzin.
- HQ
- Belgrade
Vincula Biotech Group Questions
Vincula Biotech Group's website is http://www.vinculabiotech.com
Vincula Biotech Group's LinkedIn profile is https://rs.linkedin.com/company/vincula-biotech-group
Vincula Biotech Group has
3 employees.
View email and phone details for 3
employees at Vincula Biotech Group.
Vincula Biotech Group's industry is
Biotechnology Research
Vincula Biotech Group's top competitors are
Gaiacell,
Rmos - Regenerative Medicine Orthopaedic Society,
Biocell Hospital,
Cord Ips,
Cobik,
Global Regenerative Academy Inc.,
Vincula Group,
Invetlab,
Bebac.com,
Segova Biotechnology.
Vincula Biotech Group's categories are Biotechnology Research
Vincula Biotech Group's founding year is 2017
